Mumbai: Indian pharma companies may stand to gain market share due to the potential impact of US tariffs, according to a ...
India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics , a U.S.-based immunotherapy and targeted oncology company, for $355 million.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback